Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Research

Prevalence of HBV and HCV among blood donors in Kosovo

Authors: Hajrullah Fejza, Skender Telaku

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

Hepatitis is disease of the liver caused by the infectious and non-infectious agents.
The aim of study was to analyze the prevalence of HBV and HCV among voluntary blood donors in Kosovo, during 2000–2003.
The data from National Center for Blood Transfusion of Kosovo were collected and analyzed through descriptive and comparative epidemiological method of retrospective study. All samples were tested by ELISA test.
Out of 70348 samples of the blood donors, 3145 were positive. From overall positive samples, 2939 were HBV positive, 192 HCV positive while 14 samples were positive for both viruses.
The HBV prevalence among the blood donors of Kosovo is 4.2%, which range Kosovo to the second zone according to the CDC classification of the geographical spread of the HBV infection.
The HCV prevalence among the blood donors in Kosovo is 0.3%. Compared to the other European countries this level of prevalence is relatively low.
Age group 30–39 years old was presented with 34.8% of cases. The higher number was among the workers, 842 or 26.8%.
Based on the results we can conclude that Kosovo have the similar prevalence for HBV and HCV infections as other South East European countries.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the US, 1988 through 1994. N England J Med 1999,341(8):556-62. 10.1056/NEJM199908193410802CrossRef Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the US, 1988 through 1994. N England J Med 1999,341(8):556-62. 10.1056/NEJM199908193410802CrossRef
2.
go back to reference Booth JC, O'Grady J, Neuberger J: Clinical guidelines on the management of hepatitis C. Gut 2001.,49(Suppl 1): I-I-21 Booth JC, O'Grady J, Neuberger J: Clinical guidelines on the management of hepatitis C. Gut 2001.,49(Suppl 1): I-I-21
3.
go back to reference Gerstman B: Epidemiology – kept simple. Volume Chapter 6, 9, 12, 13 & 20. Second edition. Wiley-Liss, New Jersy; 2003. Gerstman B: Epidemiology – kept simple. Volume Chapter 6, 9, 12, 13 & 20. Second edition. Wiley-Liss, New Jersy; 2003.
4.
go back to reference CDC: Updates U.S Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Post exposure Prophylaxis. MMWR 2001.,50(11): CDC: Updates U.S Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Post exposure Prophylaxis. MMWR 2001.,50(11):
5.
go back to reference Friss R, Seller ThA: Epidemiology for public health practice. Volume Chapter 12. Jones and Bartlett Publishers, London; 2004. Friss R, Seller ThA: Epidemiology for public health practice. Volume Chapter 12. Jones and Bartlett Publishers, London; 2004.
6.
go back to reference Hillyer CD, Hillyer KL, Strobe FJ, Jeffries LC, Siberstein LE: Handbook of Transfusion Medicine. Volume Chapter 2 and 32. Academic Press, London; 2001. Hillyer CD, Hillyer KL, Strobe FJ, Jeffries LC, Siberstein LE: Handbook of Transfusion Medicine. Volume Chapter 2 and 32. Academic Press, London; 2001.
7.
go back to reference Cerny A, Chisari FV: Pathogenesis of chronic hepatitis C: immunology features of hepatic injury and viral persistence. Hepatology 1999, 30: 595-601. 10.1002/hep.510300312CrossRefPubMed Cerny A, Chisari FV: Pathogenesis of chronic hepatitis C: immunology features of hepatic injury and viral persistence. Hepatology 1999, 30: 595-601. 10.1002/hep.510300312CrossRefPubMed
8.
go back to reference Mahoney FJ: Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection Clinical Microbiology Review. 1999,12(2):351-366. Mahoney FJ: Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection Clinical Microbiology Review. 1999,12(2):351-366.
9.
go back to reference Harmening DM: Modern blood banking and Transfusion Practices. Philadelphia, USA IV edition. 1999,25(6):1231-1243. Harmening DM: Modern blood banking and Transfusion Practices. Philadelphia, USA IV edition. 1999,25(6):1231-1243.
10.
go back to reference David P, Charles G, David M, Gray JA: Oxford handbook of public health practice. Oxford 2004., Chapter 1.2: David P, Charles G, David M, Gray JA: Oxford handbook of public health practice. Oxford 2004., Chapter 1.2:
12.
go back to reference Kyi KP, Aye M, Oo KM, Htun Moh, Oo SS, Lwin KO, Win KM: Prevalence of Hepatitis C in Healthy Population and Patients with Liver Ailments in Myanmar. Regional Health Forum WHO South-East Asia Region 2002.,6(1): Kyi KP, Aye M, Oo KM, Htun Moh, Oo SS, Lwin KO, Win KM: Prevalence of Hepatitis C in Healthy Population and Patients with Liver Ailments in Myanmar. Regional Health Forum WHO South-East Asia Region 2002.,6(1):
13.
go back to reference Zaller N, Nelson KE, Aladashvili M, Badridze N, del Rio C, Tsertvadze T: Risk factors for Hepatitis C virus infection among blood donors in Georgia. European Journal of Epidemiology, Netherlands 2004,19(6):547-553. 10.1023/B:EJEP.0000032352.29173.78CrossRef Zaller N, Nelson KE, Aladashvili M, Badridze N, del Rio C, Tsertvadze T: Risk factors for Hepatitis C virus infection among blood donors in Georgia. European Journal of Epidemiology, Netherlands 2004,19(6):547-553. 10.1023/B:EJEP.0000032352.29173.78CrossRef
14.
go back to reference Lauer GM, Walker BD: Hepatitis C virus infection. N England J Med 2001,345(1):45-52.CrossRef Lauer GM, Walker BD: Hepatitis C virus infection. N England J Med 2001,345(1):45-52.CrossRef
15.
go back to reference Nelson K, Wiliams CM, Graham NMH: Infectious Disease Epidemiology. Volume Chapter 19. Jones and Bartlett Publishers, London; 2004. Nelson K, Wiliams CM, Graham NMH: Infectious Disease Epidemiology. Volume Chapter 19. Jones and Bartlett Publishers, London; 2004.
16.
go back to reference Kimka N, Kingsley LA, Sayah N, Rinaldo CR: Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 1996, 72: 213-216. Kimka N, Kingsley LA, Sayah N, Rinaldo CR: Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 1996, 72: 213-216.
17.
go back to reference Gordis L: Epidemiology. Third edition. Elsevier Inc.(USA); 2004. Gordis L: Epidemiology. Third edition. Elsevier Inc.(USA); 2004.
18.
19.
go back to reference Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann H-WL, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA, for The U.S. Lamivudine Investigator Group: Lamivudine as initial treatment for chronic hepatitis B in the United States. N England J Med 1999,341(17):1256-1263. 10.1056/NEJM199910213411702CrossRef Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann H-WL, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA, for The U.S. Lamivudine Investigator Group: Lamivudine as initial treatment for chronic hepatitis B in the United States. N England J Med 1999,341(17):1256-1263. 10.1056/NEJM199910213411702CrossRef
20.
go back to reference Mailliard ME, Gollan JL: Suppressing hepatitis B without resistance – So far, so good. England J Med 2003,348(9):848-850. 10.1056/NEJMe020185CrossRef Mailliard ME, Gollan JL: Suppressing hepatitis B without resistance – So far, so good. England J Med 2003,348(9):848-850. 10.1056/NEJMe020185CrossRef
21.
go back to reference Ramadani N: Karakteristikat epidemiologjike dhe serologjike të Hepatitit B në Kosovë. PhD thesis. Universitety of Prishtina, Kosovo; 1992. Ramadani N: Karakteristikat epidemiologjike dhe serologjike të Hepatitit B në Kosovë. PhD thesis. Universitety of Prishtina, Kosovo; 1992.
22.
go back to reference Scotionitis I, Brass CA, Mallet PF: Hepatitis C: Diagnosis and Treatment. J Gen Intern Med 1995, 10: 273-282. 10.1007/BF02599887CrossRef Scotionitis I, Brass CA, Mallet PF: Hepatitis C: Diagnosis and Treatment. J Gen Intern Med 1995, 10: 273-282. 10.1007/BF02599887CrossRef
23.
go back to reference Craig S: Epidemiology of hepatitis B. The pediatric Infectious Disease Journal 1999,12(5):433-436. Craig S: Epidemiology of hepatitis B. The pediatric Infectious Disease Journal 1999,12(5):433-436.
24.
go back to reference Carrasco DA, Newman C, Tyring SK: Treatment of viral hepatitis. Harrison's Principles of Internal Medicine 14th edition. 1998, 2: 1677-92. Carrasco DA, Newman C, Tyring SK: Treatment of viral hepatitis. Harrison's Principles of Internal Medicine 14th edition. 1998, 2: 1677-92.
25.
go back to reference Hoofnagle JH: Therapy for acute hepatitis C. N England J Med 2001,345(20):1495-1497. 10.1056/NEJM200111153452013CrossRef Hoofnagle JH: Therapy for acute hepatitis C. N England J Med 2001,345(20):1495-1497. 10.1056/NEJM200111153452013CrossRef
26.
go back to reference Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N England J Med 2002,347(13):975-982. 10.1056/NEJMoa020047CrossRef Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N England J Med 2002,347(13):975-982. 10.1056/NEJMoa020047CrossRef
27.
go back to reference Greenberger NJ: Hepatitis C: More Common than suspected. Clinical focus 1995, 18-24. Greenberger NJ: Hepatitis C: More Common than suspected. Clinical focus 1995, 18-24.
28.
go back to reference Telaku S, Zekaj S, Avdijaj Xh, Elezi Y, Kuqi Xh, Zylfiu B, Rudhani I, Hasanxhekaj V, Fejza H: Prevalence of hepatitis B and C infection in dialysis patient in Kosova. The Turkish Journal of Gastroenterology 2003.,14(Supp 1): Telaku S, Zekaj S, Avdijaj Xh, Elezi Y, Kuqi Xh, Zylfiu B, Rudhani I, Hasanxhekaj V, Fejza H: Prevalence of hepatitis B and C infection in dialysis patient in Kosova. The Turkish Journal of Gastroenterology 2003.,14(Supp 1):
29.
go back to reference Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C: Epidemiology of hepatitis C virus. Transfusion 1994, 34: 135. 10.1046/j.1537-2995.1994.34294143941.xCrossRefPubMed Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C: Epidemiology of hepatitis C virus. Transfusion 1994, 34: 135. 10.1046/j.1537-2995.1994.34294143941.xCrossRefPubMed
31.
go back to reference Kosgeroglu N, Ayranci U, Vardareli E, Dincer S: Occupational exposure to hepatitis infection among Turkish nurse. In Epidemiology & Infection. Volume 132. Cambridge University Press; 2004:27-33. 10.1017/S0950268803001407 Kosgeroglu N, Ayranci U, Vardareli E, Dincer S: Occupational exposure to hepatitis infection among Turkish nurse. In Epidemiology & Infection. Volume 132. Cambridge University Press; 2004:27-33. 10.1017/S0950268803001407
32.
go back to reference Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH: Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 2000, 132: 296-305.CrossRefPubMed Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH: Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 2000, 132: 296-305.CrossRefPubMed
33.
go back to reference Robertson , Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin-i T, Simmonds P, Smith D, Stuyver L, Weiner A: Classification, nomenclature and database development for hepatitis C virus (HCV) and related viruses. Proposal for standardization. Arch Virol 1998, 143: 249-503. 10.1007/s007050050479CrossRef Robertson , Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin-i T, Simmonds P, Smith D, Stuyver L, Weiner A: Classification, nomenclature and database development for hepatitis C virus (HCV) and related viruses. Proposal for standardization. Arch Virol 1998, 143: 249-503. 10.1007/s007050050479CrossRef
Metadata
Title
Prevalence of HBV and HCV among blood donors in Kosovo
Authors
Hajrullah Fejza
Skender Telaku
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-21

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.